<h2>
<code>ovarian</code> Ovarian Cancer Survival Data</h2> <h3>Description</h3> <p>Survival in a randomised trial comparing two treatments for ovarian cancer</p> <h3>Usage</h3> <pre data-language="r">ovarian
data(cancer, package="survival")
</pre> <h3>Format</h3> <table summary="Rd table"> <tr> <td style="text-align: left;"> futime:</td>
<td style="text-align: left;"> survival or censoring time</td> </tr> <tr> <td style="text-align: left;"> fustat:</td>
<td style="text-align: left;"> censoring status</td> </tr> <tr> <td style="text-align: left;"> age: </td>
<td style="text-align: left;"> in years</td> </tr> <tr> <td style="text-align: left;"> resid.ds:</td>
<td style="text-align: left;"> residual disease present (1=no,2=yes)</td> </tr> <tr> <td style="text-align: left;"> rx:</td>
<td style="text-align: left;"> treatment group</td> </tr> <tr> <td style="text-align: left;"> ecog.ps:</td>
<td style="text-align: left;"> ECOG performance status (1 is better, see reference)</td> </tr> <tr> <td style="text-align: left;"> </td> </tr> </table> <h3>Source</h3> <p>Terry Therneau</p> <h3>References</h3> <p>Edmunson, J.H., Fleming, T.R., Decker, D.G., Malkasian, G.D., Jefferies, J.A., Webb, M.J., and Kvols, L.K., Different Chemotherapeutic Sensitivities and Host Factors Affecting Prognosis in Advanced Ovarian Carcinoma vs. Minimal Residual Disease. Cancer Treatment Reports, 63:241-47, 1979. </p><div class="_attribution">
  <p class="_attribution-p">
    Copyright (&copy;) 1999â€“2012 R Foundation for Statistical Computing.<br>Licensed under the <a href="https://www.gnu.org/copyleft/gpl.html">GNU General Public License</a>.<br>
    
  </p>
</div>
